Liver Cancer
FDA Approves Opdivo With Yervoy for Unresectable or Metastatic Hepatocellular Carcinoma
The FDA has approved nivolumab (Opdivo, Bristol Myers Squibb) with ipilimumab (Yervoy, Bristol Myers Squibb) for ...
APRIL 14, 2025
Without Effective MASLD Treatments, Cirrhosis, Cancer and Transplants Expected to Rise
Unless progress is made toward developing effective treatments for MASLD, the prevalence of the disease will ...
DECEMBER 25, 2023
NSAID, Aspirin Exposure Found to Lower Cancer, Mortality Risk in Patients With Liver Disease
Exposure to aspirin and nonsteroidal anti-inflammatory drugs is associated with a lower risk for cancer and ...
DECEMBER 6, 2023
Novel First-Line Therapy’s OS Benefit for Liver Cancer Persists
Long-term overall survival in hepatocellular carcinoma with tremelimumab plus durvalumab treatment is durable, ...
NOVEMBER 27, 2023
Tislelizumab Vies for First-Line Designation in Treatment of Advanced HCC
The checkpoint inhibitor tislelizumab might reasonably be considered a better choice for hepatocellular carcinoma ...
NOVEMBER 20, 2023
Albumin-Bilirubin Grade Proposed as Prognostic Tool in Hepatocellular Carcinoma
Results of a retrospective study suggest that the albumin-bilirubin grade might be more useful in classifying ...
NOVEMBER 11, 2023
Tremelimumab/Durvalumab Combo Promising for Unresectable HCC
Combining a single priming dose of tremelimumab and durvalumab significantly improved overall survival in the ...
FEBRUARY 10, 2022
In Meta-Analysis, Multitarget Liquid Biopsy Superior for Early HCC Detection
The results of a recent meta-analysis indicate that multitarget hepatocellular carcinoma liquid biopsy is more ...
JANUARY 31, 2022
BCLC 2022 Update Focuses on Personalizing Treatment
The Barcelona Clinic Liver Cancer (BCLC) updated its recommendations for the prognosis and treatment of liver ...
JANUARY 28, 2022
Survey Documents Pandemic’s Toll On Liver Cancer Screening
Clinicians and patients faced significant disruption in liver cancer screening during the early COVID-19 pandemic, ...
NOVEMBER 23, 2021
Early PVT Detection Crucial for Hospitalized Cirrhosis Patients With Liver Cancer
Patients with cirrhosis who also have primary liver cancer face a higher risk for complications and death when they ...
SEPTEMBER 8, 2021
Survey Documents Pandemic’s Toll On Liver Cancer Screening
Clinicians and patients faced significant disruption in liver cancer screening during the early COVID-19 pandemic, ...
JULY 20, 2021